Mepolizumab for Eosinophil-Associated COPD: Analysis of METREX and METREO.

Autor: Pavord ID; Nuffield Department of Medicine and Oxford Respiratory NIHR BRC, University of Oxford, Oxford, UK., Chapman KR; Asthma & Airway Centre, UHN and University of Toronto, Toronto, ON, Canada., Bafadhel M; Nuffield Department of Medicine and Oxford Respiratory NIHR BRC, University of Oxford, Oxford, UK., Sciurba FC; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Bradford ES; Respiratory Therapeutic Area, GSK, Research Triangle Park, NC, USA., Schweiker Harris S; Respiratory Therapeutic Area, GSK, Research Triangle Park, NC, USA., Mayer B; Clinical Statistics, GSK, Brentford, Middlesex, UK., Rubin DB; Respiratory Therapeutic Area, GSK, Research Triangle Park, NC, USA., Yancey SW; Respiratory Therapeutic Area, GSK, Research Triangle Park, NC, USA., Paggiaro P; Department of Surgery, Medicine, Molecular Biology, and Critical Care, University of Pisa, Pisa, Italy.

Publikováno v: International journal of chronic obstructive pulmonary disease [Int J Chron Obstruct Pulmon Dis] 2021 Jun 16; Vol. 16, pp. 1755-1770. Date of Electronic Publication: 2021 Jun 16 (Print Publication: 2021).